Seroatlas · Human Serome Atlas

P4HTM

Transmembrane prolyl 4-hydroxylase

Also known as: EGLN4, FLJ20262, HIFPH4, P4H-TM, P4HTM_HUMAN, PH-4, PH4, PHD4

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9NXG6
Gene
P4HTM
Ensembl
ENSG00000178467
Chromosome
3
Canonical length
502 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
Subcellular location
Vesicles,Cytosol
Quaternary structure
Homodimer

OverviewNCBI Gene

The product of this gene belongs to the family of prolyl 4-hydroxylases. This protein is a prolyl hydroxylase that may be involved in the degradation of hypoxia-inducible transcription factors under normoxia. It plays a role in adaptation to hypoxia and may be related to cellular oxygen sensing. Alternatively spliced variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

502 residues, UniProt reviewed canonical sequence.

>Q9NXG6|P4HTM
     1  MAAAAVTGQR PETAAAEEAS RPQWAPPDHC QAQAAAGLGD GEDAPVRPLC KPRGICSRAY
    61  FLVLMVFVHL YLGNVLALLL FVHYSNGDES SDPGPQHRAQ GPGPEPTLGP LTRLEGIKVG
   121  HERKVQLVTD RDHFIRTLSL KPLLFEIPGF LTDEECRLII HLAQMKGLQR SQILPTEEYE
   181  EAMSTMQVSQ LDLFRLLDQN RDGHLQLREV LAQTRLGNGW WMTPESIQEM YAAIKADPDG
   241  DGVLSLQEFS NMDLRDFHKY MRSHKAESSE LVRNSHHTWL YQGEGAHHIM RAIRQRVLRL
   301  TRLSPEIVEL SEPLQVVRYG EGGHYHAHVD SGPVYPETIC SHTKLVANES VPFETSCRYM
   361  TVLFYLNNVT GGGETVFPVA DNRTYDEMSL IQDDVDLRDT RRHCDKGNLR VKPQQGTAVF
   421  WYNYLPDGQG WVGDVDDYSL HGGCLVTRGT KWIANNWINV DPSRARQALF QQEMARLARE
   481  GGTDSQPEWA LDRAYRDARV EL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against P4HTM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.34
Highest tissue expression
161 nTPM

Expression across tissuesHPA

Tissue

  • choroid plexus: 161 nTPM
  • pituitary gland: 87 nTPM
  • cerebral cortex: 68 nTPM
  • basal ganglia: 66 nTPM
  • hypothalamus: 62 nTPM
  • hippocampal formation: 55 nTPM

Single-cell type

  • fallopian tube ciliated cells: 277 nCPM
  • respiratory ciliated cells: 246 nCPM
  • late spermatids: 230 nCPM
  • pancreatic islet cells: 150 nCPM
  • epididymal efferent duct ciliated cells: 147 nCPM
  • early spermatids: 128 nCPM

Immune cell

  • T-reg: 17 nTPM
  • naive B-cell: 16 nTPM
  • naive CD4 T-cell: 13 nTPM
  • memory CD4 T-cell: 12 nTPM
  • memory CD8 T-cell: 12 nTPM
  • MAIT T-cell: 9.6 nTPM

Brain region

  • choroid plexus: 147 nTPM
  • hypothalamus: 77 nTPM
  • cerebral cortex: 76 nTPM
  • thalamus: 69 nTPM
  • hippocampal formation: 68 nTPM
  • basal ganglia: 67 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about P4HTM.

Disease | AllUniProt

Conditions P4HTM is implicated in, by any mechanism.

Disease | GeneticClinVar

13 pathogenic / likely-pathogenic of 126 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1
gnomAD pLI
0
gnomAD missense Z
1.54
DepMap mean gene effect
-0.12
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads P4HTM as an antibody target. Whether an autoantibody or antibody against P4HTM could matter depends on whether native P4HTM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

P4HTM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label P4HTM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/P4HTM. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...